MCM
WST icon

MAI Capital Management’s West Pharmaceutical WST Stock Holding History

MAI Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-151
Closed -$37.8K – 4728
2026
Q1 		$37.8K Buy
151
+112
+287% +$27.9K ﹤0.01% 2416
2025
Q4 		$10.7K Sell
39
-12
-24% -$3.28K ﹤0.01% 2819
2025
Q3 		$13.4K Sell
51
-36
-41% -$8.75K ﹤0.01% 2608
2025
Q2 		$19K Buy
87
+78
+867% +$16.7K ﹤0.01% 2374
2025
Q1 		$2.02K Sell
9
-140
-94% -$38.6K ﹤0.01% 2971
2024
Q4 		$48.8K Buy
+149
New +$46.9K ﹤0.01% 1777
2022
Q3 		– Sell
-3,159
Closed -$955K – 1050
2022
Q2 		$955K Sell
3,159
-3
-0.1% -$976 0.02% 385
2022
Q1 		$1.3M Sell
3,162
-231
-7% -$90.4K 0.02% 342
2021
Q4 		$1.59M Buy
3,393
+6
+0.2% +$2.58K 0.03% 326
2021
Q3 		$1.44M Buy
3,387
+2
+0.1% +$843 0.03% 305
2021
Q2 		$1.22M Sell
3,385
-15
-0.4% -$4.96K 0.02% 322
2021
Q1 		$958K Buy
3,400
+19
+0.6% +$5.44K 0.02% 342
2020
Q4 		$958K Sell
3,381
-134
-4% -$37.6K 0.02% 329
2020
Q3 		$966K Sell
3,515
-905
-20% -$239K 0.03% 288
2020
Q2 		$1M Buy
+4,420
New +$868K 0.03% 281

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MAI Capital Management's WST Position: Q2 2026 in Review

MAI Capital Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 151 shares — an estimated $37.8K sold.

MAI Capital Management first reported a position in WST in Q2 2020 and held it in 15 quarters. The position peaked at $1.59M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MAI Capital Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 151 West Pharmaceutical shares in Q2 2026, an estimated $37.8K.
  • MAI Capital Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 15 quarters.
  • MAI Capital Management's West Pharmaceutical position peaked at $1.59M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.